Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®

NCT02730871 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

173

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment Challenges

Conditions

Open-angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension
DRUG: Brinzolamide/brimonidine vehicle
DRUG: Travoprost 0.004%/timolol 0.5% solution

Sponsor

Alcon Research